T1	Participants 65 87	cancer-related fatigue
T2	Participants 289 311	cancer-related fatigue
T3	Participants 363 390	Eligible adults with cancer
T4	Participants 748 802	Two hundred ninety patients were accrued to this trial
T5	Participants 1629 1651	cancer-related fatigue
